Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma – Authors’ reply

Long GV, Luke JJ, Fukunaga-Kalabis M, Ascierto PA. Lancet Oncol, 24, no. 1: e8, doi:10.1016/s1470-2045(22)00753-7. ^{TOP 10%}